A rare study on Chinese subjects yields interesting results.
Flax is known as a rich source of ALA omega-3, and limited research indicates that flax can even increase other omega-3s in the body.
Less is known of flax’s effect on people with metabolic syndrome, and even less is known of flax’s effect on people with metabolic syndrome who live in China, where flax is rarely consumed.
For 12 weeks, U.S. and Chinese researchers assigned 173 Chinese adults with risk factors of metabolic syndrome to life counseling and bread-bread containing 30 g of ground whole flaxseed (7 g of total ALA) or control bread. At baseline and the end of the study, blood samples were collected and analyzed for omega-3s and blood markers for common metabolic syndrome conditions: inflammation, oxidative stress, endothelial dysfunction, and thrombosis.
Those who consumed flax bread experienced significant increases in ALA, EPA, and DPA omega-3 and decreases in total omega-6 and ratio of omega-6 to omega-3.
But blood levels of DHA omega-3 did not increase-a finding that the researchers claim is consistent with many previous studies on Western populations. Why dietary ALA cannot individually convert to DHA in an efficient manner is still unclear. It could be related to conflicting human pathways for omega-3 conversion, it could even be that “our ancient diet, unlike modern ones, was rich in DHA; hence it is possible that the body has not developed additional means to convert sufficient DHA from ALA.”
Despite flax’s significant influence on certain omega-3s and ratio of omega-6 to omega-3, flax did not appear to benefit biomarkers of inflammation, oxidative stress, endothelial dysfunction, and thrombosis.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.